Table 3.
Perceived Importance of Discussing Race, Ethnicity, and Ancestry with Patients Undergoing Clinical Genetic Testing
| True | False | I’m not sure | |
|---|---|---|---|
| Race, ethnicity, and/or ancestry may be relevant for the following: | n = 210 | ||
| Obtaining consent | 76 (36.2%) | 108 (51.4%) | 26 (12.4%) |
| Contextualizing genetic test results | 189 (90%) | 11 (5.2%) | 10 (4.8%) |
| Tailoring treatment options | 89 (42.4%) | 52 (24.8%) | 69 (32.9%) |
| Factors motivating discussions about race, ethnicity, and ancestry with a patient: | n = 209 | ||
| Positive test result | 101 (48.3%) | 55 (26.3%) | 53 (26.4%) |
| Negative test result | 62 (29.7%) | 71 (34%) | 76 (36.4%) |
| Variant of uncertain significance (VUS) result | 104 (49.8%) | 63 (30.1%) | 41 (19.6%) |
| Patient is from a racial or ethnic minority group | 111 (53.1%) | 70 (33.5%) | 28 (13.4%) |
Survey respondents who see patients responded to true/false questions about the type of clinical functions for which race, ethnicity, or ancestry may be relevant, in addition to factors that might motivate them to discuss these with a patient.